Skip to content

Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients

The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03326622
Enrollment
48
Registered
2017-10-31
Start date
2013-07-01
Completion date
2015-06-30
Last updated
2017-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Keywords

Amyotrophic Lateral Sclerosis, aerobic exercise, functional outcome, non-invasive ventilation, oxygen uptake

Brief summary

This study evaluated the influence of a tailored aerobic exercise protocol on the functional outcome in ALS patients. In addition, the investigators compare some CPET variables collected during exercise testing in both groups.

Detailed description

This work aimed to evaluate the effects of a moderate aerobic exercise with controlled intensity determined by Cardiopulmonary Exercise Testing (CPET) and its role on the functional status in ALS patients versus standard care. Additionally, the investigators explored the performance of CPET variables - oxygen uptake (VO2) expressed in L/min, in percentage of predicted or in metabolic equivalents (METs) at peak effort, at anaerobic threshold (AT), the respiratory compensation point (RCP) when achieved, Dioxide Carbon output in L/min (VCO2) and the minute ventilation in L/min (VE) throughout the study. Assessments:(diagnostic visit - T0), at study entry (T1) and 6 months after (T2) using: Functional status by Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R), Respiratory function tests (RFT): Forced Vital Capacity predicted (%FVC) and Oxygen saturation provided by pulse oximetry. CPET was performed in both groups at study entry and 6 months later (T1 and T2), using a treadmill (WOODWAY®) coupled with a gas exchange analyzer (METALYZER® 3B) with ergo-spirometry system using a breath-by-breath technology developed by CORTEX® systems. Intervention: G1(Interventional group) performed moderate exercise protocol two times/week in a treadmill in the lower range of the training zone determined by CPET + standard care (range of motion exercise, gait and balance training under continuous pulse oximetry observation). G2 (control group) performed a standard care exercise program at home or at other rehabilitation units without pulse oximetry observation.

Interventions

OTHERstandard care

A standard care program based on American Academy of Neurology guidelines (Range Of Motion (ROM) exercises, gait and balance training )at home or another rehabilitation units without intensity control.

A moderate exercise protocol two times per week in a treadmill in the lower range of the training zone determined by Cardiopulmonary Exercise Testing, monitored by continuous pulse oximetry evaluation.

Sponsors

University of Lisbon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

single blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Consecutive patients diagnosed with definite, probable, or probable laboratory supported ALS * Disease duration from first symptoms between 6-24 months to exclude slow and fast progression * ALSFRS-R ≥ 30 * FVC (%predicted) ≥ 70%

Exclusion criteria

* Other medical conditions, like cardiac insufficiency and lung disorders or others conditions limiting exercise training; * Heavy smoking habits with laboratorial evidence of significant bronchial constriction; * Signs of associated dementia or psychiatric disorders. Note: None of the patients were on tube feeding, invasive or non-invasive mechanical ventilation at admission of study protocol (T1).

Design outcomes

Primary

MeasureTime frameDescription
Functional decline between start and end of the studybetween baseline and 6 months laterIt was used the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R),which rates the functionality of the ALS patients in performing activities involving 4 different areas through 3 sub-scores - bulbar, spinal \[upper and lower limb\] and also the respiratory function. Each of its questions is rated from 0 (total inability) to 4 points (no functional limitation). The last three questions address the respiratory function (dyspnea, orthopnea, respiratory insufficiency) and assess the respiratory functional outcome. The sub-scores rating: Bulbar sub-score between 0 - 12, the spinal score between 0 - 24 and the respiratory sub-score between 0 - 12.The sum of the sub-scores provide an ALSFRS-R total score = 48. Higher values represent a better functionality.

Secondary

MeasureTime frameDescription
Performance of Cardiopulmonary Exercise testing variables throughout the studyat study entry and 6 months later.Changes on the oxygen uptake (VO2peak) measurement following an aerobic exercise protocol compared to standard care.
Changes on the Dioxide Carbon output (VCO2) measurementat study entry and 6 months laterChanges on the Dioxide Carbon output (VCO2) following an aerobic exercise protocol compared to standard care.
Changes on the Minute Ventilation (VE) measurementat study entry and 6 months laterChanges on Minute ventilation (VE) following an aerobic exercise protocol compared to standard care.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026